Annual EBITDA
-$2.84 M
+$3.46 M+54.88%
December 1, 2023
Summary
- As of March 1, 2025, IBO annual EBITDA is -$2.84 million, with the most recent change of +$3.46 million (+54.88%) on December 1, 2023.
- IBO annual EBITDA is now -442.87% below its all-time high of -$523.70 thousand, reached on December 1, 2019.
Performance
IBO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$4.83 M
+$5.17 M+1503.20%
September 1, 2024
Summary
- As of March 1, 2025, IBO quarterly EBITDA is $4.83 million, with the most recent change of +$5.17 million (+1503.20%) on September 1, 2024.
- Over the past year, IBO quarterly EBITDA has increased by +$5.32 million (+1089.14%).
- IBO quarterly EBITDA is now at all-time high.
Performance
IBO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$3.14 M
+$5.62 M+226.42%
September 1, 2024
Summary
- As of March 1, 2025, IBO TTM EBITDA is $3.14 million, with the most recent change of +$5.62 million (+226.42%) on September 1, 2024.
- Over the past year, IBO TTM EBITDA has increased by +$6.00 million (+209.60%).
- IBO TTM EBITDA is now at all-time high.
Performance
IBO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IBO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.9% | +1089.1% | +209.6% |
| 3 y3 years | - | +1136.1% | +380.9% |
| 5 y5 years | -442.9% | +1136.1% | +380.9% |
IBO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.9% | at high | +193.1% | at high | +145.8% |
| 5 y | 5-year | -442.9% | +54.9% | at high | +193.1% | at high | +145.8% |
| alltime | all time | -442.9% | +54.9% | at high | +193.1% | at high | +145.8% |
Impact BioMedical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.83 M(-1503.2%) | $3.14 M(-226.4%) |
| Jun 2024 | - | -$344.00 K(-29.5%) | -$2.48 M(-13.3%) |
| Mar 2024 | - | -$488.00 K(-43.0%) | -$2.86 M(+0.7%) |
| Dec 2023 | -$2.84 M(-54.9%) | -$856.00 K(+7.7%) | -$2.84 M(-58.5%) |
| Sep 2023 | - | -$795.00 K(+9.7%) | -$6.86 M(+2.8%) |
| Jun 2023 | - | -$725.00 K(+54.9%) | -$6.67 M(+5.4%) |
| Mar 2023 | - | -$468.00 K(-90.4%) | -$6.33 M(+2.1%) |
| Dec 2022 | -$6.30 M | -$4.87 M(+702.0%) | -$6.19 M(-4.8%) |
| Sep 2022 | - | -$607.00 K(+58.9%) | -$6.51 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$382.00 K(+14.0%) | -$6.37 M(+2.4%) |
| Mar 2022 | - | -$335.00 K(-93.5%) | -$6.22 M(-1.3%) |
| Dec 2021 | -$6.30 M(+1103.2%) | -$5.18 M(+1012.5%) | -$6.30 M(+463.8%) |
| Sep 2021 | - | -$465.90 K(+100.3%) | -$1.12 M(+34.6%) |
| Jun 2021 | - | -$232.60 K(-44.5%) | -$830.10 K(-0.4%) |
| Mar 2021 | - | -$419.00 K(+134.7%) | -$833.30 K(+42.9%) |
| Sep 2020 | - | -$178.50 K(-24.3%) | -$583.00 K(+13.1%) |
| Jun 2020 | - | -$235.80 K(+39.8%) | -$515.70 K(+84.2%) |
| Dec 2019 | -$523.70 K | -$168.70 K(+51.7%) | -$279.90 K(+151.7%) |
| Sep 2019 | - | -$111.20 K | -$111.20 K |
FAQ
- What is Impact BioMedical annual EBITDA?
- What is the all time high annual EBITDA for Impact BioMedical?
- What is Impact BioMedical annual EBITDA year-on-year change?
- What is Impact BioMedical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Impact BioMedical?
- What is Impact BioMedical quarterly EBITDA year-on-year change?
- What is Impact BioMedical TTM EBITDA?
- What is the all time high TTM EBITDA for Impact BioMedical?
- What is Impact BioMedical TTM EBITDA year-on-year change?
What is Impact BioMedical annual EBITDA?
The current annual EBITDA of IBO is -$2.84 M
What is the all time high annual EBITDA for Impact BioMedical?
Impact BioMedical all-time high annual EBITDA is -$523.70 K
What is Impact BioMedical annual EBITDA year-on-year change?
Over the past year, IBO annual EBITDA has changed by +$3.46 M (+54.88%)
What is Impact BioMedical quarterly EBITDA?
The current quarterly EBITDA of IBO is $4.83 M
What is the all time high quarterly EBITDA for Impact BioMedical?
Impact BioMedical all-time high quarterly EBITDA is $4.83 M
What is Impact BioMedical quarterly EBITDA year-on-year change?
Over the past year, IBO quarterly EBITDA has changed by +$5.32 M (+1089.14%)
What is Impact BioMedical TTM EBITDA?
The current TTM EBITDA of IBO is $3.14 M
What is the all time high TTM EBITDA for Impact BioMedical?
Impact BioMedical all-time high TTM EBITDA is $3.14 M
What is Impact BioMedical TTM EBITDA year-on-year change?
Over the past year, IBO TTM EBITDA has changed by +$6.00 M (+209.60%)